Friday, February 25, 2011

Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment

PurposeCholine derivatives labelled with positron emitters are successfully used for PET imaging of prostate cancer patients. Since little is known about uptake mechanisms, the aim of this study was to characterize choline uptake in prostate cancer cells, also following anti-androgen treatment or chemotherapy.

No comments: